These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 30700946)

  • 1. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.
    Biolato M; Manca F; Marrone G; Cefalo C; Racco S; Miggiano GA; Valenza V; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Jan; 25(4):509-520. PubMed ID: 30700946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.
    Nier A; Brandt A; Conzelmann IB; Özel Y; Bergheim I
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction.
    Krawczyk M; Maciejewska D; Ryterska K; Czerwińka-Rogowska M; Jamioł-Milc D; Skonieczna-Żydecka K; Milkiewicz P; Raszeja-Wyszomirska J; Stachowska E
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
    Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.
    Gelli C; Tarocchi M; Abenavoli L; Di Renzo L; Galli A; De Lorenzo A
    World J Gastroenterol; 2017 May; 23(17):3150-3162. PubMed ID: 28533672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study.
    Abenavoli L; Greco M; Milic N; Accattato F; Foti D; Gulletta E; Luzza F
    Nutrients; 2017 Aug; 9(8):. PubMed ID: 28805669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study.
    Pataky Z; Genton L; Spahr L; Lazarevic V; Terraz S; Gaïa N; Rubbia-Brandt L; Golay A; Schrenzel J; Pichard C
    Dig Dis Sci; 2016 Sep; 61(9):2721-31. PubMed ID: 27142672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease.
    Aller R; de Luis DA; Izaola O; de la Fuente B; Bachiller R
    Eur Rev Med Pharmacol Sci; 2014; 18(7):1041-7. PubMed ID: 24763885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease.
    Abenavoli L; Greco M; Nazionale I; Peta V; Milic N; Accattato F; Foti D; Gulletta E; Luzza F
    Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):519-27. PubMed ID: 25617046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease.
    Kontogianni MD; Tileli N; Margariti A; Georgoulis M; Deutsch M; Tiniakos D; Fragopoulou E; Zafiropoulou R; Manios Y; Papatheodoridis G
    Clin Nutr; 2014 Aug; 33(4):678-83. PubMed ID: 24064253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): study protocol.
    Papamiltiadous ES; Roberts SK; Nicoll AJ; Ryan MC; Itsiopoulos C; Salim A; Tierney AC
    BMC Gastroenterol; 2016 Feb; 16():14. PubMed ID: 26831892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocaloric high-protein diet improves clinical and biochemical markers in patients with nonalcoholic fatty liver disease (NAFLD).
    Bezerra Duarte SM; Faintuch J; Stefano JT; Sobral de Oliveira MB; de Campos Mazo DF; Rabelo F; Vanni D; Nogueira MA; Carrilho FJ; Marques Souza de Oliveira CP
    Nutr Hosp; 2014 Jan; 29(1):94-101. PubMed ID: 24483967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions.
    Trovato FM; Catalano D; Martines GF; Pace P; Trovato GM
    Clin Nutr; 2015 Feb; 34(1):86-8. PubMed ID: 24529325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
    Shidfar F; Bahrololumi SS; Doaei S; Mohammadzadeh A; Gholamalizadeh M; Mohammadimanesh A
    Can J Gastroenterol Hepatol; 2018; 2018():1053710. PubMed ID: 29850450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis of randomized controlled trials: effects of mediterranean diet and low-fat diet on liver enzymes and liver fat content of NAFLD.
    Xiong Y; Shi X; Xiong X; Li S; Zhao H; Song H; Wang J; Zhang L; You S; Ji G; Liu B; Wu N
    Food Funct; 2024 Aug; 15(16):8248-8257. PubMed ID: 39076035
    [No Abstract]   [Full Text] [Related]  

  • 17. The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.
    Marin-Alejandre BA; Abete I; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martinez JA; Zulet MA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31652512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ad Libitum Mediterranean and Low-Fat Diets Both Significantly Reduce Hepatic Steatosis: A Randomized Controlled Trial.
    Properzi C; O'Sullivan TA; Sherriff JL; Ching HL; Jeffrey GP; Buckley RF; Tibballs J; MacQuillan GC; Garas G; Adams LA
    Hepatology; 2018 Nov; 68(5):1741-1754. PubMed ID: 29729189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development.
    Liu JP; Zou WL; Chen SJ; Wei HY; Yin YN; Zou YY; Lu FG
    World J Gastroenterol; 2016 Aug; 22(32):7353-64. PubMed ID: 27621581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis.
    Takayama S; Katada K; Takagi T; Iida T; Ueda T; Mizushima K; Higashimura Y; Morita M; Okayama T; Kamada K; Uchiyama K; Handa O; Ishikawa T; Yasukawa Z; Okubo T; Itoh Y; Naito Y
    World J Gastroenterol; 2021 May; 27(18):2160-2176. PubMed ID: 34025071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.